The phase one clinical trial for imatinib in cancer patients in the late 1990s showed efficacy with consecutive patients responding as the dose was escalated.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.